thinprep® pap test system (Cytyc Corporation)
Structured Review
Thinprep® Pap Test System, supplied by Cytyc Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/thinprep+pap+test+solution/thinprep+pap+test/us07862702-34-7-3
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Association Between Common Vaginal Infections and Cervical Non–Human Papillomavirus (HPV) 16/18 Infection in HPV-Vaccinated Women Article Snippet: Cervical cytology was tested annually using the ThinPrep PapTest ( Article Title: Efficacy of the AS04-adjuvanted HPV-16/18 vaccine in young Chinese women with oncogenic HPV infection at baseline: post-hoc analysis of a randomized controlled trial Article Snippet: Cervical cytology was tested using the ThinPrep PapTest ( Article Title: Pattern of multiple human papillomavirus infection and type competition: An analysis in healthy Chinese women aged 18–45 years Article Snippet: Cervical cytology specimens from all women were collected in PreservCytTM solution for Article Title: Polymorphisms in the Nonhomologous End-joining DNA Repair Pathway are Associated with HPV Integration in Cervical Dysplasia Article Snippet: Study procedures included the completion of a risk factor questionnaire; a complete medical history; full physical and gynecologic examinations; regular and Article Title: Effects of anti-PD-1 immunotherapy on tumor regression: insights from a patient-derived xenograft model. Article Snippet: Leukocyte identification in peripheral blood (in vivo) and in tumor stroma (ex vivo)Complete peripheral blood (conserved in EDTA tubes) and cell suspensions from tumor tissue were processed by flow cytometry using a FACSCanto II instrument and FACSDiva software v6.1.2 (BD Biosciences; Franklin Lakes, NJ, USA). Article Title: Clinical performance of the aptima HPV assay in 4196 women with positive high-risk HPV and ASC-US cytology: A large women hospital experience. Article Snippet: Correspondence Chengquan Zhao, MD, Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA 16066, USA.. Email: zhaoc@upmc.edu Abstract Background: Despite Aptima assay as the latest US Food Drug Administration (FDA)approved high-risk human papillomavirus (hrHPV) test has been implemented as an adjunct in cervical cancer screening for years, histological follow-up data remain limited with respect to its performance in women with ASC-US Pap tests and positive hrHPV results.. Methods: Cases with results of ASC-US cytology and positive hrHPV by Aptima assay during the period 06/ 2015–02/2017 were retrieved from archived pathology reports. Article Title: Cervical Screening in North Sardinia (Italy): Genotype Distribution and Prevalence of HPV among Women with ASC-US Cytology Article Snippet: Cervical specimens were collected with cervix-brush and suspended in a 20 mL Article Title: Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women Article Snippet: Cervical cytology samples were collected on day 1 for Pap testing ( |
